Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Giroux

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Organic Chemistry|September 11, 2020
Application of a Dual Catalytic Nickel/Iridium-Based Photoredox Reaction to Synthesize 2-Alkyl-<i>N</i>-Arylindoles in a Continuous FlowJasmin C Wilson, Michael J Boyd, Simon Giroux, et al.
Journal of the American Chemical Society|November 6, 2003
Application of conformation design in acyclic stereoselection: total synthesis of borrelidin as the crystalline benzene solvateStephen Hanessian, Yang Yang, Simon Giroux, et al.
The Journal of Organic Chemistry|August 10, 2018
C-H Functionalization of Heteroarenes Using Unactivated Alkyl Halides through Visible-Light Photoredox Catalysis under Basic ConditionsNoah B Bissonnette, Michael J Boyd, Gregory D May, et al.
Bioorganic & Medicinal Chemistry Letters|December 1, 2020
ROCK inhibitors 4: Structure-activity relationship studies of 7-azaindole-based rho kinase (ROCK) inhibitorsUpul K Bandarage, John Court, Huai Gao, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 23, 2012
Induction of anti-anti-idiotype antibodies against sulfated glycosaminoglycans reduces atherosclerosis in apolipoprotein E-deficient miceVíctor Brito, Katia Mellal, Simon Giroux Portelance, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ InhibitorsUpul K Bandarage, Alex M Aronov, Jingrong Cao, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Discovery of Potent, Selective Triazolothiadiazole-Containing c-Met InhibitorsQing Tang, Alex M Aronov, David D Deininger, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Thienoimidazole-Based HCV NS5A Genotype 1a and 1b InhibitorsSimon Giroux, Jinwang Xu, T Jagadeeswar Reddy, et al.
Bioorganic & Medicinal Chemistry Letters|January 19, 2015
Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 2: non-symmetric inhibitors with potent activity against genotype 1a and 1bSimon Giroux, Darius Bilimoria, Caroline Cadilhac, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2015
Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 1: C2-symmetric inhibitors with diyne and biphenyl linkersSimon Giroux, Darius Bilimoria, Caroline Cadilhac, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Organic Chemistry|September 11, 2020
Application of a Dual Catalytic Nickel/Iridium-Based Photoredox Reaction to Synthesize 2-Alkyl-<i>N</i>-Arylindoles in a Continuous FlowJasmin C Wilson, Michael J Boyd, Simon Giroux, et al.
Journal of the American Chemical Society|November 6, 2003
Application of conformation design in acyclic stereoselection: total synthesis of borrelidin as the crystalline benzene solvateStephen Hanessian, Yang Yang, Simon Giroux, et al.
The Journal of Organic Chemistry|August 10, 2018
C-H Functionalization of Heteroarenes Using Unactivated Alkyl Halides through Visible-Light Photoredox Catalysis under Basic ConditionsNoah B Bissonnette, Michael J Boyd, Gregory D May, et al.
Bioorganic & Medicinal Chemistry Letters|December 1, 2020
ROCK inhibitors 4: Structure-activity relationship studies of 7-azaindole-based rho kinase (ROCK) inhibitorsUpul K Bandarage, John Court, Huai Gao, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 23, 2012
Induction of anti-anti-idiotype antibodies against sulfated glycosaminoglycans reduces atherosclerosis in apolipoprotein E-deficient miceVíctor Brito, Katia Mellal, Simon Giroux Portelance, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ InhibitorsUpul K Bandarage, Alex M Aronov, Jingrong Cao, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Discovery of Potent, Selective Triazolothiadiazole-Containing c-Met InhibitorsQing Tang, Alex M Aronov, David D Deininger, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Thienoimidazole-Based HCV NS5A Genotype 1a and 1b InhibitorsSimon Giroux, Jinwang Xu, T Jagadeeswar Reddy, et al.
Bioorganic & Medicinal Chemistry Letters|January 19, 2015
Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 2: non-symmetric inhibitors with potent activity against genotype 1a and 1bSimon Giroux, Darius Bilimoria, Caroline Cadilhac, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2015
Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 1: C2-symmetric inhibitors with diyne and biphenyl linkersSimon Giroux, Darius Bilimoria, Caroline Cadilhac, et al.
Pageof 3